Multiple Myeloma Highlights From ASCO 2022 Multiple Myeloma Highlights From ASCO 2022

Dr Jonathan Kaufman reviews key studies on multiple myeloma presented at ASCO 2022, including the phase 3 DETERMINATION trial, a quadruple induction therapy study, and updated results from MajesTEC-1.Medscape

Source: Medscape Today Headlines - June 28, 2022 Category: Consumer Health News Tags: None ReCAP Source Type: news